Compliance with Immunoglobulin Therapy In Patients with Primary Immunodeficiency (PIDD) Treated at Home

Compliance with treatment is a key factor to optimize outcomes in patients with chronic conditions such as PIDD. Since treatment compliance data in this population is limited, we assessed compliance in PIDD patients receiving immunoglobulin therapy intravenously (IV) or subcutaneously (SC).

Saved in:

Bibliographic Details
Published in:	Journal of allergy and clinical immunology Vol. 127; no. 2; p. AB18
Main Authors:	Bonnet, P.O, Yoon, A.H, Xiong, Y
Format:	Journal Article
Language:	English
Published:	St. Louis Mosby, Inc 01-02-2011 Elsevier Limited
Subjects:	Allergy and Immunology Compliance Drug therapy Medical research
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Compliance with treatment is a key factor to optimize outcomes in patients with chronic conditions such as PIDD. Since treatment compliance data in this population is limited, we assessed compliance in PIDD patients receiving immunoglobulin therapy intravenously (IV) or subcutaneously (SC).
ISSN:	0091-6749 1097-6825
DOI:	10.1016/j.jaci.2010.12.082